Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg for initiation (not for glycemic control)
Early studies have compared its effects with single- and dual-agonist approaches to evaluate the magnitude and durability of metabolic effects
Karampatsi D, Zabala A, Wilhelmsson U et al (2021) Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke
Eden is not affiliated with or endorsed by Eli Lilly and Company.
Other common, and often minor, side effects can include headache, fatigue, dizziness, irritation around the injection site, and general lack of energy
US$ 22.51
US$ 26.61
US$ 25.33
